Conor Hale

SAN FRANCISCO—GE HealthCare is launching a new imaging research collaboration with the University of California, San Francisco, aimed at improving the diagnosis of neurodegenerative diseases and cancer.

The FDA is elevating a recall from Philips related to one of its wearable outpatient heart monitors, used to help detect cases of hidden, transient arrhythmias that may only last minutes at a time.

WuXi AppTec is parting ways with its U.S. medical device testing business, selling its two stateside locations to the Ohio-based regulatory consulting firm NAMSA.

While medical device shortages are nothing new, the FDA said it is becoming more concerned that supply chain disruptions are having greater impacts

Inflammatix has secured the FDA's blessing for its in vitro diagnostic system, aimed at rapidly profiling the body's response to an infectious disease at the point of care.

Among his first actions as president, Donald Trump has rescinded an executive order signed during the Biden administration that directed the

For the full calendar of 2024, Abbott recorded sales of $41.95 billion, following the launches last year of a new heart valve repair implant and FDA clearances for two over-the-counter blood sugar trackers, among other products.

After its long-time chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO.

Roche has obtained U.S. government green lights allowing its point-of-care testing system to be used to screen for multiple sexually transmitted infections from a single sample.

With the full-scale launch of its latest surgical robot set for the middle of this year, Intuitive said that, to date, the limited rollout of its